Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03705416 · ClinicalTrials.gov registry record
Long Term Outcomes of Bariatric Patients Treated With Surgery or Endoscopy
A clinical trial of Obesity and GERD, sponsored by Johns Hopkins University.
- Active
- Registry status
- 250
- Enrollment target
- 6
- Study locations
NCT03705416: Active study of Obesity and GERD, sponsored by Johns Hopkins University.
NCT03705416 is a study of Obesity and GERD that is active but no longer recruiting, run by Johns Hopkins University. The registered enrollment target is 250 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (69% lower). The trial reports 6 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03705416, a study of Obesity and GERD, is active but no longer recruiting, sponsored by Johns Hopkins University.
- ACTIVE NOT RECRUITING
- Registry status
- 250 participants
- Enrollment target
- 6
- Study locations
Study Summary
GERD is common in the obese population. Bariatric procedures are the mainstay of therapy for these patients. Bariatric procedures can be surgical (Roux-en-Y gastric bypass and Vertical sleeve gastrectomy) or endoscopic (endoscopic sleeve gastroplasty). The rate of GERD after either treatment is unknown as is the rate of silent reflux. The study primary objective is to assess the incidence rate of GERD in bariatric patients that undergo either therapy.
Primary Outcome
GERD symptoms, esophageal acid exposure time and/or esophagitis
Interventions
- PROCEDURE Surgery
- PROCEDURE Endoscopy
Study Locations (6)
New York
- Northwell Health - New Hyde Park
- Weill Cornell - New York
Maryland
- Johns Hopkins University - Baltimore
Oregon
- Legacy Oregon Clinic - Portland
Texas
- Memorial Hermann Health System - Houston
Utah
- Utah-Health: University of Utah - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2019-03-30 |
| Est. Completion | 2028-03-30 |
What the registry record for NCT03705416 still lists
NCT03705416 is an observational study that tracks outcomes without assigning an intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (69% lower).
The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Surgery is the first listed.
NCT03705416 lists 6 locations in 5 states (New York, Maryland, Oregon).
Frequently Asked Questions
What is clinical trial NCT03705416 about?
NCT03705416 is a clinical study titled "Long Term Outcomes of Bariatric Patients Treated With Surgery or Endoscopy". GERD is common in the obese population. Bariatric procedures are the mainstay of therapy for these patients. Bariatric procedures can be surgical (Roux-en-Y gastric bypass and Vertical sleeve gastrectomy) or endoscopic (endoscopic sleeve gastroplasty). The rate of GERD after either treatment is unkn...
What is the current status of trial NCT03705416?
This trial is currently active not recruiting. The enrollment target is 250 participants. The study started on 2019-03-30. Estimated completion is 2028-03-30.
What conditions does trial NCT03705416 study?
This clinical trial studies the following conditions: Obesity, GERD.
What interventions are being tested in trial NCT03705416?
The interventions under investigation include: Surgery (PROCEDURE), Endoscopy (PROCEDURE).
Who is sponsoring clinical trial NCT03705416?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03705416 being conducted?
This trial has 6 study locations across Maryland, New York, Oregon, Texas, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03705416's enrollment target sits among peer trials
250 255th of 1053 higher than 789 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Hip Flexion Feedback System for Exercise Monitoring in Individuals With Osteoarthritis and Obesity
RECRUITING · Phase 1
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity
RECRUITING · Phase 2
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI